Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
1,3-diol-containing molecules are a class of organic compounds characterized by two hydroxyl groups separated by a single carbon atom. This structural motif is a hallmark of various biologically active natural products, including polyene macrolide antibiotics like amphotericin B and various polyketides (PubChem, 2024). In medicinal chemistry, the 1,3-diol arrangement is a critical pharmacophore in HMG-CoA reductase inhibitors (statins), where it mimics the natural substrate's transition state to inhibit cholesterol synthesis (NIH, 2023). Despite their prevalence in drug structures, 1,3-diols are not therapeutic targets themselves; rather, they are chemical features of the ligands that bind to targets such as enzymes or cell membrane components. Because this term refers to a broad chemical classification rather than a specific biological macromolecule, it is not considered a valid therapeutic target in a pharmacological context (Wikipedia, 2024). The synthesis of these motifs often requires sophisticated stereoselective methods, such as the Evans-Saksena reduction, highlighting their complexity in drug design (Journal of Organic Chemistry, 2022).
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 1,3-diol-containing molecules.